Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Switching Studies, Human Factors Analyses Are Flashpoints For Industry

Jun 01 2017

• By Sue Sutter

Related Content

Biosimilar User Fee Agreement Puts FDA On Hook For Delayed Guidances

Sep 22 2016

Biosimilar Interchangeability: How To Design A Multiple-Switch Study

Jan 19 2017

Next Steps For Interchangeable Biosimilars: Lifecycle Regulation Policy Development

Jan 18 2017

Related Companies

Johnson & Johnson

Genentech, Inc.

Momenta Pharmaceuticals, Inc.

Novartis AG

Amgen, Inc.

AbbVie Inc.

Additional Topics

United States Biosimilars Clinical Trials Drug Approval Standards Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window